Pharmacologic rescue of motor and sensory function by the neuroprotective compound P7C3 following neonatal nerve injury
- 1 January 2015
- journal article
- Published by Elsevier in Neuroscience
- Vol. 284, 202-216
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institute of Health Research
- National Institute of Health
- Plastic Surgery Foundation
- National Institutes of Mental Health
This publication has 85 references indexed in Scilit:
- Functional recovery following peripheral nerve injury in the transgenic Thy1‐GFP ratJournal of the Peripheral Nervous System, 2013
- Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosisProceedings of the National Academy of Sciences, 2012
- Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson diseaseProceedings of the National Academy of Sciences, 2012
- Contractile properties and movement behaviour in neonatal rats with axotomy, treated with the NMDA antagonist DAP5BMC Physiology, 2012
- Riluzole Treatment Reduces Motoneuron Death Induced by Axotomy in Newborn RatsJournal of Neurotrauma, 2012
- Surgical management of facial nerve paralysis in the pediatric populationJournal of Pediatric Surgery, 2011
- Development of Proneurogenic, Neuroprotective Small MoleculesJournal of the American Chemical Society, 2011
- Discovery of a Proneurogenic, Neuroprotective ChemicalCell, 2010
- Role of PAF Receptor in Proinflammatory Cytokine Expression in the Dorsal Root Ganglion and Tactile Allodynia in a Rodent Model of Neuropathic PainPLOS ONE, 2010
- Permanent changes in muscle and motoneurones induced by nerve injury during a critical period of development of the ratDevelopmental Brain Research, 1987